Ruxolitinib Cream Shows Promise for Hidradenitis Suppurativa

Source link :

SAN DIEGO — Patients with mild hidradenitis suppurativa (HS) treated with ruxolitinib cream experienced a greater reduction in the abscess and inflammatory nodule (AN) count from baseline to week 16 than those who applied a vehicle cream, in a phase 2 trial. “HS is a chronic, recurring inflammatory skin disease that is associated with painful […]

Author : News Health

Publish date : 2024-04-03 07:29:14

Copyright for syndicated content belongs to the linked Source.

Exit mobile version